WHWK Aadi Bioscience Inc: Bozor kapitallashuvining balans qiymatiga nisbati

aadibio.com (WHWK) - korporativ logo

Aadi Bioscience Inc (WHWK) mTOR inhibitorlaridan foydalangan holda noyob o'smalar uchun maqsadli dori vositalarini ishlab chiqishga e'tibor qaratadi hamda Fyarro savdolarining o'sishi va sotib olish potentsialidan foydalanadi. Xavf-xatarlarni kamaytirish strategiyasi aniq mutatsiyalarni davolashga asoslangan bo'lib, bu nisha segmentlarda raqobatbardosh ustunlikni ta'minlaydi. Ushbu narxlar grafigi aktivning dinamikasini aks ettiradi, bunda ko'rsatkich 0.97 darajasida turibdi. Rivojlanish vektori albumin nanoparticles va R&D portfelini yangilashga yo'naltirilgan.

Aadi Bioscience (WHWK) - Bozor kapitallashuvining balans qiymatiga nisbati 20.03.2025dan 27.10.2026gacha

WHWK (Aadi Bioscience Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi aadibio.com|WHWK - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Aadi Bio|WHWK - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Aadi Bioscience|WHWK - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati aadibio.com|WHWK - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Aadi Bioscience Inc|WHWK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati aadibio.com|WHWK - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Aadi Bio
Fundamental baholash:WHWK (Aadi Bioscience, Inc.)
Aadi Bioscience Inc tayyor mahsulotlari

Ushbu ko'rsatkich bozor narxining kapital sifati va pul oqimlariga bo'lgan sezuvchanligini aks ettiradi. U bozor kapitalizatsiyasining kapitalga nisbati orqali sof aktivlar qiymati bo'yicha bozor konsensusini o'lchaydi. Aadi Bioscience Inc (WHWK) uchun ushbu hisob-kitob Fyarro dori vositasining salohiyatini va TSC1/TSC2 mutatsiyalarini davolashdagi muvaffaqiyatlarni hisobga oladi. Kompaniyaning bozor qiymatining uning balans qiymatiga nisbatini tahlil qilish aktivlarning haddan tashqari sotib olingan holatlarini aniqlash imkonini beradi. Investorlar ushbu grafikdagi keskin ko'tarilishlar paytida impulsiv savdolardan qochishlari kerak.

Asosiy raqobatchilar

ONC: Bozor qiymatining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp|Bozor kapitallashuvining balans qiymatiga nisbati OSTX|Bozor kapitallashuvining balans qiymatiga nisbati Radiopharm Theranostics Ltd (RADX)|Bozor kapitallashuvining balans qiymatiga nisbati ARTV (Artiva Biotherapeutics)|Bozor kapitallashuvining balans qiymatiga nisbati Adlai Nortye Ltd ANL|Veru Pharma (VERU) - Bozor kapitallashuvining balans qiymatiga nisbati|TPST - Kapitallashuvning balans qiymatiga nisbati|xiliotx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Renovaro|MURA - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Kairos Pharma Inc|Bozor kapitallashuvining balans qiymatiga nisbati OnKure Therapeutics Inc (OKUR)|Bozor qiymatining balans qiymatiga nisbati w2.cytomed.sg (GDTC)|Bozor kapitallashuvining balans qiymatiga nisbati CRIS|Apollomics Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi|THAR (Tharimmune) - Bozor qiymatining balans qiymatiga nisbati|ADVB: Bozor qiymatining balans qiymatiga koeffitsiyenti|Genprex, Inc - Bozor qiymatining balans qiymatiga nisbati|Calidi Biotherapeutics, Inc. (CLDI) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SBFM|Kapitallashuvning sof aktivlarga nisbati Xenetic Bio|SLRX (Salarius Pharmaceuticals, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Purple Biotech Ltd (PPBT)|AONC: Bozor kapitallashuvining balans qiymatiga nisbati|BeiGene Ltd - Bozor qiymatining balans qiymatiga koeffitsiyenti|Checkpoint Therapeutics (CKPT) - Bozor qiymatining balans qiymatiga nisbati|ELEV - Kapitallashuvning balans qiymatiga nisbati|ICAD (icadmed.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Ikena Oncology (IKNA) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NTBL (Notable Labs Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Viracta (VIRX)|MorphoSys AG (MOR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati nayabiosciences.com (NAYA)|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV